All years

17 October 2016 - IMI SAFE-T and C-Path PSTC Obtain Regulatory Support For New Liver Safety Biomarkers

FDA and EMA Letters of Support Pave the Way for Clinical Qualification The Innovative Medicines Initiative (IMI) SAFE-T (Safer and Faster Evidence Based Translation) Consortium and The Critical Path Institute (C-Path) announced today that the U.S.


14.10.2016 - NMI levels up to core site for the CiPA myocyte study

We are very excited that HESI changed our status from non-core to core site for the actual running CiPA myocyte study.


Startschuss für den Forschungscampus „BioMedTech“

Ministerin Hoffmeister-Kraut übergibt Zuwendungsbescheid in Höhe von insgesamt 4,2 Millionen Euro


SIGNATOPE: NMI bringt weiteres Start-Up auf den Weg

Gründer bieten neue Biomarker-Testverfahren für die frühzeitige Erkennung von Nebenwirkungen bei der Medikamentenentwicklung


DigiWest® multiplex protein profiling technology published in Nature Communications

Reutlingen, Germany, September 26, 2016 – The Natural and Medical Sciences Institute at the University of Tübingen (NMI), a private research foundation, and its contract research provider NMI TT Pharmaservices today announced the publication of their